Blueprint Medicines Wins FDA Approval For AYVAKIT Efficacy
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212608
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 15)
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves.
Pharma/Biotech Companies Highlight Upcoming Presentations At American Society Of Clinical Oncology Jun. 4-8, 2021
Cullinan Oncology (CGEM) - https://www.globenewswire.com/news-release/2021/05/19/2232874/0/en/Cullinan-Oncology-to-Provide-CLN-081-Clinical-Update-at-ASCO-2021.html
BeiGene (BGNE)
70 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ:GNPX) shares surged 64.4% to close at $1.89 on Wednesday after climbing 219.44% on Tuesday.…
Blueprint Medicines Prices 4.7M Share Public Offering of Shares of Common Stock @$69/Share
Blueprint Medicines Corporation (NASDAQ:BPMC) announced the pricing of an underwritten public offering of 4,710,144 shares of its common…
98 Biotechnology Stocks Moving In Wednesday’s Session
Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock increased by 131.7% to $3.36 during Wednesday’s regular session. • Genprex, Inc.…
116 Healthcare Stocks Moving In Wednesday’s Session
Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock moved upwards by 133.1% to $3.38 during Wednesday’s regular session. • Genprex,…
46 Stocks Moving In Wednesday’s Mid-Day Session
Gainers Neurotrope, Inc. (NASDAQ:NTRP) shares jumped 114.5% to $3.11 after the company announced it was awarded $2.7 million…
8 Stocks To Watch For January 22, 2020
Some of the stocks that may grab investor focus today are: Wall Street expects Abbott Laboratories (NYSE:ABT) to…